GlobeNewswire 11/16/2020 IMMINENT SHAREHOLDER DEADLINE: BioMarin Pharmaceutical, Inc. Sued for Violations of the Federal Secu...

GlobeNewswire 11/13/2020 BMRN UPCOMING DEADLINE: Zhang Investor Law Alerts Investors to Imminent Deadline in Securities Class...

GlobeNewswire 11/12/2020 IMPORTANT NOV. 24 DEADLINE – BMRN - Pawar Law Group Announces a Securities Class Action Lawsuit Agai...

GlobeNewswire 11/12/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, GOCO, NKLA INVESTORS of Lead Plaintiff Deadline in...

GlobeNewswire 11/8/2020 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 11/7/2020 ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Nove...

GlobeNewswire 11/7/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, GOCO, NKLA INVESTORS of Lead Plaintiff Deadline in...

GlobeNewswire 11/5/2020 Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Development...

GlobeNewswire 11/5/2020 BMRN DEADLINE: Zhang Investor Law Alerts Investors to Looming Deadline in Securities Class Action La...

GlobeNewswire 11/4/2020 SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against BioMarin P...

GlobeNewswire 11/3/2020 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 11/3/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, GOCO, NKLA INVESTORS of Lead Plaintiff Deadline in Clas...

GlobeNewswire 11/2/2020 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates BMRN, CACC, GOCO Investors on Securities Class Acti...

GlobeNewswire 10/29/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, COTY, GOCO, NKLA INVESTORS of Lead Plaintiff Deadline i...

GlobeNewswire 10/28/2020 SHAREHOLDER ALERT: BioMarin Pharmaceutical, Inc. Sued for Violations of the Federal Securities Laws;...

GlobeNewswire 10/26/2020 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates BMRN, CACC, GOCO Investors on Securities Class Acti...

GlobeNewswire 10/25/2020 ROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadlin...

GlobeNewswire 10/24/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, CACC, TRQ INVESTORS of Lead Plaintiff Deadline in ...

GlobeNewswire 10/22/2020 ROSEN, GLOBAL INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline...

GlobeNewswire 10/20/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, CACC, TRQ INVESTORS of Lead Plaintiff Deadline in ...

GlobeNewswire 10/15/2020 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, CACC INVESTORS of Lead Plaintiff Deadline in Class...

GlobeNewswire 10/14/2020 SHAREHOLDER ALERT: BioMarin Pharmaceutical, Inc. Sued for Violations of the Federal Securities Laws;...

GlobeNewswire 10/14/2020 BMRN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages BioMarin Pharmaceutical (BM...

GlobeNewswire 10/12/2020 ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds BioMarin Pharmaceutical Inc. Investors of Import...

GlobeNewswire 10/8/2020 BMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BioMarin Pharmaceutical Inc. Sha...